Review article · 2020 · Open access

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg

Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin A. Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andréasson, Erik Portelius, Nicholas James Ashton, Kaj Blennow, Michael Schöll and 3 more

Alzheimer s Research & Therapy, 12(1), 20 · Published 28 February 2020 · DOI 10.1186/s13195-020-00586-6

Open PDFView at the publisherCite this paper

In brief

“Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg” is a 2020 review article by Pawel Obrocki and 14 co-authors, published in Alzheimer s Research & Therapy. OpenAlex counts 56 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Alzheimer s Research & Therapy.

Citations
56
Most cited in
2022 (19)
Field-weighted impact
1.13
References
129
Authors
15

Abstract

Until relatively recently, a diagnosis of probable Alzheimer's disease (AD) and other neurodegenerative disorders was principally based on clinical presentation, with post-mortem examination remaining a gold standard for disease confirmation. This is in sharp contrast to other areas of medicine, where fluid biomarkers, such as troponin levels in myocardial infarction, form an integral part of the diagnostic and treatment criteria. There is a pressing need for such quantifiable and easily accessible tools in neurodegenerative diseases.In this paper, based on lectures given at the 2019 Biomarkers in Neurodegenerative Diseases Course, we provide an overview of a range of cerebrospinal fluid (CSF) and blood biomarkers in neurodegenerative disorders, including the 'core' AD biomarkers amyloid β (Aβ) and tau, as well as other disease-specific and general markers of neuroaxonal injury. We then highlight the main challenges in the field, and how those could be overcome with the aid of new methodological advances, such as assay automation, mass spectrometry and ultrasensitive immunoassays.As we hopefully move towards an era of disease-modifying treatments, reliable biomarkers will be essential to increase diagnostic accuracy, allow for earlier diagnosis, better participant selection and disease activity and treatment effect monitoring.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Obrocki, P., Khatun, A., Ness, D., Senkevich, K. A., Hanrieder, J., Capraro, F., Mattsson, N., Andréasson, U., Portelius, E., Ashton, N. J., Blennow, K., Schöll, M., Paterson, R. W., Schott, J. M., & Zetterberg, H. (2020). Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg. Alzheimer s Research & Therapy, 12(1), 20. https://doi.org/10.1186/s13195-020-00586-6

MLA 9

Obrocki, Pawel, et al. “Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg.” Alzheimer s Research & Therapy, vol. 12, no. 1, 2020, p. 20. https://doi.org/10.1186/s13195-020-00586-6.

Chicago

Obrocki, Pawel, Ayesha Khatun, Deborah Ness, Konstantin A. Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, et al. 2020. “Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg.” Alzheimer s Research & Therapy 12 (1): 20. https://doi.org/10.1186/s13195-020-00586-6.

Harvard

Obrocki, P. et al. (2020) ‘Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg’, Alzheimer s Research & Therapy, 12(1), p. 20. doi:10.1186/s13195-020-00586-6.

IEEE

P. Obrocki et al., “Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg,” Alzheimer s Research & Therapy, vol. 12, no. 1, p. 20, 2020, doi: 10.1186/s13195-020-00586-6.

BibTeX

@article{obrocki2020perspectives,
  title     = {{Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg}},
  author    = {Obrocki, Pawel and Khatun, Ayesha and Ness, Deborah and Senkevich, Konstantin A. and Hanrieder, Jörg and Capraro, Federica and Mattsson, Niklas and Andréasson, Ulf and Portelius, Erik and Ashton, Nicholas James and Blennow, Kaj and Schöll, Michael and Paterson, Ross W. and Schott, Jonathan M. and Zetterberg, Henrik},
  journal   = {Alzheimer s Research \& Therapy},
  year      = {2020},
  volume    = {12},
  number    = {1},
  pages     = {20},
  doi       = {10.1186/s13195-020-00586-6},
  url       = {https://doi.org/10.1186/s13195-020-00586-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201911
202011
202188
20221919
20231010
202488
202555
202644

Its field-weighted citation impact is 1.13: it has been cited 1.13 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • fluid biomarkers
  • neurodegenerative diseases
  • Alzheimer's disease
  • cerebrospinal fluid biomarkers
  • blood biomarkers
  • amyloid-beta
  • tau protein
  • neuroaxonal damage

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Obrocki, P., Khatun, A., Ness, D., Senkevich, K. A., Hanrieder, J., Capraro, F., Mattsson, N., Andréasson, U., Portelius, E., Ashton, N. J., Blennow, K., Schöll, M., Paterson, R. W., Schott, J. M., & Zetterberg, H. (2020). Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg. Alzheimer s Research & Therapy, 12(1), 20. https://doi.org/10.1186/s13195-020-00586-6

How many times has this paper been cited?

56 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Alzheimer s Research & Therapy: sign in and open the PDF from this page.

Who wrote this paper?

Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin A. Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andréasson, Erik Portelius, Nicholas James Ashton, Kaj Blennow, Michael Schöll and 3 more.

What is the DOI of this paper?

10.1186/s13195-020-00586-6, permanently at https://doi.org/10.1186/s13195-020-00586-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.